| Specialty Retail Industry | Consumer Discretionary Sector | David J. Cutler CEO | OTC PINK Exchange | 83412T104 CUSIP |
| US Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Solanbridge Group, Inc. is a company founded in 2000, with its headquarters located in The Woodlands, Texas. It operates in the cannabis industry, focusing on the production and sale of medical marijuana and CBD-infused products. The company's operations span across North America, with specific attention to Nova Scotia, Canada for medical marijuana, and Nevada, California, and Colorado for its CBD product lines. Solanbridge Group, Inc. aims to leverage the growing acceptance and legalization of cannabis products for medicinal and recreational purposes to expand its market reach and diversify its product offerings.
Solanbridge Group, Inc. plans to produce and distribute medical marijuana in Nova Scotia, Canada. This effort targets patients who are prescribed cannabis for various therapeutic purposes, aligning with Canadian regulations on medical cannabis. By entering the Canadian medical marijuana market, the company aims to meet the growing demand for quality-controlled and legally compliant cannabis products for medicinal use.
The company also focuses on the development, production, and sale of CBD-infused products in the U.S. states of Nevada, California, and Colorado. These products range from edibles and topicals to tinctures and capsules that are infused with Cannabidiol (CBD), a non-psychoactive compound found in cannabis. Targeting wellness-conscious consumers, Solanbridge's CBD products are designed to offer various health benefits, such as pain relief, anxiety reduction, and improved sleep, without the high associated with THC.